Use of certain common antiviral drugs during a recent influenza B epidemic in Japan showed the development of viruses with partial resistance to the drugs, according to a study in the April 4 issue of JAMA.
A research team at the University of Rochester Medical Center has been awarded $26 million to establish a research center with the goal of making seasonal influenza and future influenza pandemics less deadly.
The University of Alaska Fairbanks announced today a $3.8 million award for its role in one of six National Institutes of Health Centers of Excellence for Influenza Research and Surveillance to study influenza viruses with pandemic potential, such as avian influenza H5N1.
Novavax Inc.’s virus-like particle (VLP) vaccine triggered a robust immune response and provided protection against the H9N2 strain of avian influenza, according to pre-clinical data published in the online edition of the journal Vaccine.
One of the persistent riddles of the deadly 1918 Spanish influenza pandemic is why it struck different cities with varying severity. Why were some municipalities such as St. Louis spared the fate of the hard-hit cities like Philadelphia when both implemented similar public health measures?
Institutes of Health has awarded the University of Georgia a $7.4 million contract to collaborate with Emory University through its new Regional Center for Excellence for Influenza Research and Surveillance. Emory and UGA will receive a total of $32.8 million over seven years from the NIH National Institute of Allergy and Infectious Diseases to establish one of six new national influenza centers.
Among a group of mostly older male veterans suffering from chronic obstructive pulmonary disease (COPD), an illness that offers greater susceptibility to lung cancer, researchers found that the regular use of high-dose inhaled corticosteroids (ICS) lowered the risk of developing lung cancer.
The National Institute of Allergy and Infectious Disease, part of the National Institutes of Health, today named the University of Minnesota as one of six sites across the country that will establish a Center of Excellence for Influenza Research and Surveillance.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced it is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance.
A WHO background document will be used to help guide discussions and stir debate. The paper profiles eight issues linked to international health security, together with key points to focus the debate: